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A B S T R A C T
The purpose of this study was to investigate the eﬀects of Tanacetum Parthenium Extract (TPE) on Lipid per-
oxidation, antioxidant enzymes, biochemical factors, and liver enzymes in the rats damaged by Carbon
Tetrachloride (CCl4).
54 male Wistar rats were divided into 9 groups each consisting of 6 rats. Two of the groups were control
groups (normal and damage control groups), 4 of them were exposure groups which were respectively ad-
ministered with 40, 80, and 120 mg/kg of TPE and silymarin for 14 days before being damaged by CCl4, and the
other 3 groups were post-treatment groups which received 80 and 120 mg/kg of TPE and silymarin 2, 6, 24, and
48 h after being injected with CCl4. At the end of the study, biochemical factors, serum liver enzymes, mal-
ondialdehyde level, antioxidant enzymes, and liver morphology were assayed.
Pre- and post-treatment with TPE could signiﬁcantly decrease ALT, AST, ALP, TG, LDL, TC, and glucose levels
and increase HDL, and albumin levels and catalase, SOD, and GPx activities compared to the CCl4-damaged
control group.
The results of this study are indicative of the antioxidant activity of TPE, its potential hepatoprotective eﬀects,
and its probable therapeutic properties for laboratory animals damaged by CCl4.
1. Introduction
Liver is one of the main organs involved in the metabolism of drugs
and toxic chemicals and is the ﬁrst target organ for almost all chemicals
[1,2]. Most of the xenobiotics enter the body through gastrointestinal
tract and after absorption enter the liver through portal vein. The liver
has a high concentration of toxin-metabolizing enzymes which can
convert xenobiotics to compounds with low toxicity and excrete them.
However, sometimes toxic substances are converted to active metabo-
lites during metabolism which can exacerbate liver damage and cause
changes in the macroscopic structure of, or damage to, speciﬁc mole-
cules such as bile acid transporters, families of nuclear receptors, in-
tracellular lipids, proteins, and nucleic acids [3]. Improper performance
of these molecules activates some secondary paths which ﬁnally lead to
planned events such as apoptosis, necrosis, autophagy, mitochondrial
defects, and immune responses [4]. Moreover, the entire cellular
function is also disrupted by cytolytic activities and the destruction of
membranes and transmembrane transport mechanisms.
CCl4 is the most recognized chemical substance used in developing
models of liver and kidney damage [5,6]. Therefore, CCl4-induced liver
damage is one of the best ways of inducing damage by xenobiotics and
also one of the common methods of screening hepatoprotective or liver
treatment drugs. The metabolism of CCl4 begins with the formation of
trichloromethyl and proxy chloromethyl free radicals via the activity of
oxygenase system of cytochrome P450 in endoplasmic reticulum. The
trichloromethyl radical reacts with various important biological sub-
stances such as fatty acids, proteins, lipids, nucleic acids, and amino
acids [7,8].
Therefore, the antioxidant activity of the body and the inhibition of
the production of free radicals are important in preventing CCl4-in-
duced hepatopathies. In CCl4-induced liver damages, the balance be-
tween Reactive Oxygen Species (ROS) production and antioxidant de-
fense system is disturbed due to oxidative stress which disrupts cellular
functions through some events and causes liver damage and necrosis.
Despite the considerable advancements in medicine and modern
pharmacology, drugs used for the treatment of liver damages have
many side eﬀects and exacerbate the disease. Therefore, it is necessary
to ﬁnd new drugs to replace those with many side eﬀects [9,10]. Non-
Alcoholic Fatty Liver Disease (NAFLD) includes a wide spectrum of liver
damages from simple fatty liver to steatohepatitis, steatonecrosis, and
non-alcoholic steatohepatitis. The aims of treatment in NAFLD are
weight loss for obesity, reduction of lipid-lowering agents for
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dyslipidemia, modifying antioxidants and probiotics for oxidative
stress, cytoprotective agents for apoptosis, and anti-tumor necrosis
factor (TNF-α) for proinﬂammatory cytokines. Thus, it seems necessary
to ﬁnd a compound that has hepatoprotective and antihyperlipidemic
eﬀects without causing other side eﬀects [11–13].
TPE with the common name of ‘Feverfew’ is a plant belonging to the
family of Asteraceae which is used for the treatment of various diseases
such as arthritis and migraine in traditional medicine. This plant con-
tains various antioxidant compounds such as sesquiterpene lactone and
various ﬂavonoids [14]). Therefore, this study was conducted with the
aim of assaying the eﬀects of TPE on lipid peroxidation, antioxidant
enzymes, biochemical factors, and liver enzymes in the rats damaged by
CCl4.
2. Materials and methods
2.1. Chemical substances
Commercial kits of superoxide dismutase and glutathione perox-
idase were bought from Randox Company (Crumlin, UK) and those of
AST, ALP, ALT, TG, TC, Urea, HDL, and glucose were purchased from
Pars Azmoon Company (Tehran, Iran). Chemical substances including
hydrogen peroxide, methanol, thiobarbituric acid, bovine serum al-
bumin, coomassie blue, CCl4, ferric sulfate, ferric chloride, sodium
acetate, and butanol were purchased from Merck Company (Germany).
TPTZ and ketamine were bought from Fluka Company and Alphasan
Company (Netherlands), respectively.
2.2. Plant collection and extraction
The plant samples were collected at the humidity level of 45–60%
early in May from Khodafarin, Arasbaran Zone, East Azarbayjan
Province, Iran which is situated at the altitude of 2100 m above sea
level. After conﬁrmation of the genus and species, which was done
using valid identiﬁcation keys by the herbarium experts of the Research
Center for Agriculture and Natural Resources of East Azarbayjan
Province with the herbarium code of 2411, the samples were prepared
for extraction. The aerial parts of the plant were dried separately in
shadow at the ambient temperature of 20–25 °C and then powdered
using a mortar. After that, they were soaked in methanol 70% for
7 days. The obtained extract was percolated and then condensed by
rotary evaporator. After the evaporation of alcohol, the extract was
deposited in a freeze dryer at main drying and ﬁnal drying phases for 2
weeks to become powder and then kept in a freezer.
2.3. The design of the study
2.3.1. Selection of animals
In this study, male Albino Wistar rats with body weights of
180 ± 20 g were purchased from Faculty of Veterinary Medicine,
Tehran University. They were kept in standard conditions, that is, the
temperature of about 22 °C, 12-h light/dark cycle, and in a bed of straw.
This study was approved by the Ethics Committee of Ardabil University
of Medical Sciences and the identiﬁcation code received for it from the
Clinical Trials Registry of Islamic Republic of Iran is
‘IR.ARUMS.REC.1394.67’.
2.3.2. Induction of liver damage
In order to induce liver damage in rats, CCl4 was solved in olive oil
with the ratio of 1:1 and from the obtained mixture 1.5 mg/kg was
injected to them intraperitoneally [15].
2.3.3. Grouping of the rats
54 rats were randomly assigned to 9 groups each consisting of 6
rats.
Group 1 (NC): This group was the normal group in which the rats
received distilled water via gavage for 14 days and were injected with
1.5 mg/kg of just olive oil (the solvent of CCl4) on the 14th day.
Group 2 (CC): This group was the exposure group in which the rats
received distilled water via gavage for 14 days and were injected with
1.5 mg/kg of CCl4 and olive oil mixture on the 14th day.
Group 3 (bTP40): This group was the pretreatment group with the
dose of 40 in which the rats were administered with 40 mg/kg TPE for
14 days and received 1.5 mg/kg of CCl4 and olive oil mixture on the
14th day.
Group 4 (bTP80): This group was the pretreatment group with the
dose of 80 in which the rats were administered with 80 mg/kg TPE for
14 days and received 1.5 mg/kg of CCl4 and olive oil mixture on the
14th day.
Group 5 (bTP120): This group was the pretreatment group with the
dose of 120 in which the rats were administered with 120 mg/kg TPE
for 14 days and received 1.5 mg/kg of CCl4 and olive oil mixture on the
14th day.
Group 6 (bSC100): This group was the positive control group with
the standard drug silymarin. The rats in this group were administered
with 100 mg/kg silymarin for 14 days and received 1.5 mg/kg of CCl4
and olive oil mixture on the 14th day.
Group 7 (aTP80): This group was the post-treatment group with the
dose of 80 in which the rats were administered with 1.5 mg/kg of CCl4
and olive oil mixture on the 14th day and received 80 mg/kg TPE via
gavage 2, 6, 24, and 48 h after the injection of CCl4.
Group 8 (aTP120): This group was the post-treatment group with the
dose of 120 in which the rats were administered with 1.5 mg/kg of CCl4
and olive oil mixture on the 14th day and received 120 mg/kg TPE via
gavage 2, 6, 24, and 48 h after the injection of CCl4.
Group 9 (aSC100): This group was the post-treatment group with
silymarin in which the rats were administered with 1.5 mg/kg of CCl4
and olive oil mixture on the 14th day and received 100 mg/kg silymarin
via gavage 2, 6, 24, and 48 h after the injection of CCl4.
50 h after the last injection, the rats were anesthetized with the
injection of 200 μl (160 μl ketamine 10% + 40 μl xylazine) of an-
esthesia agent. Then their abdominal areas were opened and the blood
samples were directly taken from their hearts. The samples were cen-
trifuged at 3000 rpm for 10 min and after making aliquots in vials of
1.5 ml were stored in a freezer at −80 °C to perform biochemical ex-
periments.
Immediately after blood collection, a piece of each rat’s liver (right-
distal lobe) was removed and kept in formalin 10% for histopatholo-
gical examinations. A part of their livers was also washed with saline
and kept in liquid nitrogen.
2.4. Measurement of serum factors
Serum levels of ALT, AST and ALP were measured using standard
assay kits according to the manufacturer's instructions. The con-
centrations of glucose, cholesterol, and triglyceride were measured with
GOD-POP, CHOD-POP, and GPO-POP methods, respectively. Direct
measurement method was used to determine HDL-C and LDL-C con-
centrations while albumin was measured through bromocresol green
method according to the instructions provided by Pars Azmoon kit
(Tehran, Iran). The experiments were conducted according to the in-
structions provided in each laboratory kit using an Auto-Analyzer
(Biochemistry Analyzer BT 1500, Italy).
2.5. Preparation of tissue lysate
200 mg of liver was chopped and poured in a tube and 2 ml of
homogenization buﬀer (tris buﬀer) was added to it. Then, it was
homogenized at 10,000 rpm for 2 min in a homogenizer set. The ob-
tained suspension was centrifuged at 12,000 rpm for 20 min so that the
unhomogenized cells deposit. The pure homogenous solution was used
in the measurement of malondialdehyde, superoxide dismutase, and
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glutathione peroxidase.
2.6. Measurement of malondialdehyde (MDA) in liver
MDA was measured according to Mihara & Uchiyama’s method with
slight modiﬁcations. In summary, 400 μl of the supernatant liquid of the
homogenized tissue was solved in 400 μl of trichloroacetic acid. After
centrifugation, 400 μl of supernatant liquid was mixed with 2400 μl of
phosphoric acid (1%). After vortexing, 1 ml thiobarbituric acid (0.67%)
was added to the test tube and after being vortexed once again was
placed in a boiling bain-marie for 60 min. After getting cold, 1600 μl n-
butanol was added to the samples and they were vortexed once again
for 1–2 min. Then, they were centrifuged at 3000 rpm for 10 min. After
separating the organic phase (supernatant solution), light absorption
was measured in the wavelength of 532 nm against n-butanol as the
blank. After transferring the obtained results to 1,1,3,3-tetra-
ethoxypropane standard curve, MDA concentration of the samples were
determined [16].
2.7. Measurement of superoxide dismutase (SOD) activity
The measurement of SOD was done according to the instructions of
Randox kit. The basis for the reaction of SOD is the production of free
radicals by xanthine and xanthine oxidase (XOD). These free radicals
react with substrate 2-(4-iodophenyl)-3-(4-nitrophenyl)-5-phenylte-
trazolium chloride (I.N.T) and produce dye molecules. Superoxide
dismutase inhibits this reaction. The level of this inhibition depends
upon the concentration of superoxide dismutase.
2.8. Measurement of glutathione peroxidase activity (GPx)
Measurement of GPx was done according to the instructions of
Randox kit with Valentine and Paglia’s method. First, the reduced
glutathione was oxidized by glutathione peroxidase. Then, the oxidized
glutathione was converted to reduced glutathione in the presence of
glutathione reductase and NADPH. The decrease of light absorption as
the result of conversion of NADPH to NADPH+ is correlated with GPx
concentration.
2.9. Measurement of tissue catalase activity
After removing the liver and homogenization in phosphate buﬀer
(PH = 7), the pure homogeneous solution was used to measure catalase
activity with hydrogen peroxide as the substrate. Catalase was mea-
sured through Aebi method. In summary, 50 μl centrifuged supernatant
liquid was diluted 500 times with phosphate buﬀer. Then, 2 μl of this
solution was poured in a cuvette. 1 ml of 30 mM hydrogen peroxide was
added to it and the absorption variations were monitored at the wa-
velength of 240 nm against the blank in 1 min. The chemical reaction
was triggered with the addition of hydrogen peroxide and then the
enzyme activity was calculated [17].
2.10. Assay of total antioxidant capacity (TAC)
It was measured by ferric reducing ability of tissue (FRAP) method.
This method is based on the ability of tissue in reducing Fe 3+ to Fe 2+
in the presence of TPTZ. The reaction of Fe 2+ and TPTZ gives a
complex with blue color and maximum absorbance in 593 nm [18].
2.11. Morphological and histopathological studies
After anesthetization and getting blood samples from the heart of
the rats, their abdominal areas were opened and a piece of their liver
was removed for macroscopic, histopathological, and biochemical
analyses. The livers were identiﬁed and observed for any gross ap-
pearance and color change. The liver tissue was sliced and pieces were
ﬁxed in 10% formalin, dehydrated in graduated ethanol (50–100%),
cleared in xylene, and embedded in paraﬃn. Sections 4–5 μm thick
were prepared and then stained with hematoxylin and eosin (H–E) dye
and examined for histopathological changes under the microscope
(Olympus IX71).
2.12. Protein assay
The protein was assayed via Bradford method which is based on the
binding of coomassie blue dye to proteins [19].
2.13. Statistical analysis
All of the results were reported in the form of ‘mean ± standard
deviation’ and the analysis was done through one-way ANOVA. The
signiﬁcance level was taken as (P < 0.05). To conduct supplementary
analysis, post hoc test was employed. All of the statistical analyses were
performed using SPSS 16.0 software.
3. Results
3.1. The eﬀect of TPE on biochemical factors
The eﬀects of TPE on various biochemical factors in the groups
under study are given in Tables 1 and 2. The CCl4-damaged rats (CC)
showed a signiﬁcant increase in ALT, AST, ALP, cholesterol, trigly-
ceride, LDL, and glucose levels while their albumin and HDL levels
decreased signiﬁcantly compared with the control group (NC)
(P < 0.001). Pretreatment with 40, 80, and 120 mg/kg of TPE for
14 days as well as post-treatment with 80 and 120 mg/kg of TPE 2, 6,
24, and 48 h after the injection of CCl4 led to the decrease of ALT, AST,
ALP, TC, TG, LDL, and glucose levels and increase of albumin and HDL
levels. The doses of 40 mg/kg in pretreatment and 80 mg/kg in post-
treatment did not have a signiﬁcant eﬀect on some biochemical factors.
Table 1
Eﬀect of TPE on liver enzymes, albumin, and glucose.
Groups AST ALT ALP albumin Glucose
NC 156 ± 7.29 60.66 ± 3.88 621.83 ± 20.01 2.92 ± 0.11 110.33 ± 10.46
CC 1975 ± 75.9* 1290 ± 59.16* 1535 ± 72.07* 1.8 ± 0.13* 152.14 ± 12.29*
bTP40 1915 ± 48.88 1215 ± 89.38** 1495 ± 58.9 1.89 ± 0.08 145 ± 8.07
bTP80 1773 ± 68.01† 1120 ± 47.74† 1446.66 ± 49.66** 2.02 ± 0.21** 134.16 ± 15.61**
bTP120 1613 ± 56.09† 1011.66 ± 89.31† 1396.66 ± 60.88† 2.15 ± 0.23† 129.16 ± 14.17†
bSC100 1511 ± 39.7† 848.33 ± 73.05† 1338.33 ± 49.56† 2.25 ± 0.27† 126 ± 15.4†
aTP80 1913 ± 62.18 1261 ± 47.9 1515 ± 54.03 1.94 ± 0.08 135.82 ± 13.28**
aTP120 1858 ± 63.69† 1201 ± 47.9** 1446 ± 25.03** 2 ± 0.15** 135.16 ± 12.81**
aSC100 1730 ± 82.2† 1113 ± 46.33† 1418 ± 51.15† 2.11 ± 0.16** 132 ± 13.82**
Results presented in the table were expressed as the mean values ± standard deviation (SD) for 6 rats in each group. * shows the signiﬁcance of diﬀerences relative to the normal control
group (P < 0.001). ** and † show signiﬁcance of diﬀerences relative to the damage control group (P < 0.05 and P < 0.001 respectively).
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3.2. The eﬀect of TPE on lipid peroxidation levels
Comparison of tissue MDA in CCl4-damaged rats (CC) with the
healthy rats (NC) indicated a signiﬁcant increase in MDA level after the
induction of oxidative stress (P < 0.001). However, pretreatment with
the doses of 80 and 120 mg/kg and post-treatment with the dose of
120 mg/kg TPE decreased the level of lipid peroxidation which resulted
in the decrease of MDA level compared to the group without treatment
(Fig. 1). Silymarin also decreased lipid peroxidation level in both pre-
and post-treatment groups.
3.3. Comparing the levels of oxidative stress factors in the groups under
study
Comparing the levels of antioxidant catalase, superoxide dismutase,
and glutathione peroxidase in the tissues of CCl4-damaged rats (CC)
with healthy rats (NC) demonstrated a signiﬁcant decrease in the levels
of these enzymes after the induction of damage and inﬂammation
(P< 0.001). However, pretreatment with the doses of 40, 80, and
120 mg/kg and post-treatment with the dose of 120 mg/kg TPE could
prevent the decrease in the activities of catalase, superoxide dismutase,
and tissue glutathione peroxidase compared to the group without
treatment (Figs. 2–4). Moreover, silymarin signiﬁcantly increased an-
tioxidant enzymes in the damaged rats in both pre- and post-treatment
groups. Fig. 5 shows the eﬀect of TPE on plasma total antioxidant ca-
pacity in CCl4-damaged rats. The level of eﬀectiveness increases with
the increase in the dose of TPE in both pre- and post-treatment groups.
Therefore, it seems that the eﬀect of TPE on plasma total antioxidant
capacity is dependent on the dose.
3.4. The eﬀect of TPE on histopathology of liver tissue
Morphological examination of rat liver tissue at the end of the study
showed the visible pale, gross, and irregular surface suggesting the
severe hepatocellular damage in CCl4-treated rats as compared to
normal control group. Pretreatment with 120 mg/kg TPE as well as
pretreatment with 100 mg/kg silymarin somewhat protected the liver
from CCl4-induced injuries (Fig. 6).
The hepatoprotective eﬀect of TPE on CCl4-induced liver damage
was further conﬁrmed by histopathological examinations. The liver
Table 2
Comparison of lipid proﬁle in study groups.
Groups Cholesterol TAG LDL HDL
NC 54.33 ± 4.41 58.5 ± 4.63 4.8 ± 3.08 37.83 ± 1.72
CC 80.28 ± 4.34* 90.57 ± 5.25* 44.02 ± 3.81* 18.14 ± 1.4*
bTP40 78.33 ± 6.83 86.66 ± 6.68 40.36 ± 7.05 20.63 ± 1.4**
bTP80 73.5 ± 3.56** 82 ± 2.68** 34.61 ± 3.66† 22.48 ± 0.75†
bTP120 71.5 ± 3.14† 78.16 ± 4.07† 31.63 ± 3.28† 24.23 ± 1.37†
bSC100 67.5 ± 3.88† 74.5 ± 4.63† 27.46 ± 4.53† 25.13 ± 1.57†
aTP80 76.8 ± 3.6 86 ± 5.05 39.9 ± 2.9 19.7 ± 1.17**
aTP120 72.33 ± 4.27** 80.33 ± 3.7† 35.2 ± 3.9† 21.01 ± 1.44†
aSC100 70.5 ± 4.41† 76.5 ± 3.39† 33.15 ± 4.3† 22.05 ± 0.07†
Results presented in the table were expressed as the mean values ± standard deviation
(SD) for 6 rats in each group. * shows the signiﬁcance of diﬀerences relative to the normal
control group (P < 0.001). ** and † show signiﬁcance of diﬀerences relative to the
damage control group (P < 0.05 and P < 0.001 respectively).
Fig. 1. The eﬀect of pretreatment with TPE on MDA level in CCl4-damaged rats. The bar
signs on top of the columns indicate mean ± standard deviation (n = 6). * shows the
signiﬁcance of diﬀerences relative to the normal control group (P < 0.001). ** shows the
signiﬁcance of diﬀerences relative to the exposure group (P < 0.05). † shows sig-
niﬁcance of diﬀerences relative to the damage control group (P < 0.001).
Fig. 2. The eﬀect of TPE on the level of superoxide dismutase (SOD) in CCl4-damaged
rats. The bar signs on top of the columns indicate mean ± standard deviation (n = 6). *
shows the signiﬁcance of diﬀerences relative to the normal control group (P < 0.001). †
shows signiﬁcance of diﬀerences relative to the damage control group (P < 0.001).
Fig. 3. The eﬀect of TPE on the level of glutathione peroxidase (GPx) enzyme in CCl4-
damaged rats. The bar signs on top of the columns indicate mean ± standard deviation
(n = 6). * shows the signiﬁcance of diﬀerences relative to the normal control group
(P < 0.001). † shows signiﬁcance of diﬀerences relative to the damage control group
(P < 0.001).
Fig. 4. The eﬀect of TPE on the level of catalase (CAT) enzyme in CCl4-damaged rats. The
bar signs on top of the columns indicate mean ± standard deviation (n = 6). * shows the
signiﬁcance of diﬀerences relative to the normal control group (P < 0.001). ** shows the
signiﬁcance of diﬀerences relative to the exposure group (P < 0.05). † shows sig-
niﬁcance of diﬀerences relative to the damage control group (P < 0.001).
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samples administered with only CCl4 indicated damages such as va-
cuolization of cells, more percentages of necrosis, dilation of disse
space, inﬁltration of inﬂammatory cells, bridging necrosis, and degen-
eration of biliary. However, in the groups administered with TPE, less
percentages of necrosis were observed both in pre- and post-treatment
groups. Moreover, tissue healing after necrosis and degeneration of
biliary in livers showed that TPE can be compared with standard drug
silymarin in terms of its eﬀectiveness on the tissue (Fig. 7).
4. Discussion
The ﬁndings of this study demonstrated that injection of CCl4 to rats
induces severe liver damage which is detected due to the increase in the
serum levels of AST, ALT, and ALP. Damage to liver cells changes their
functional transition, causes membrane permeability, and leads to the
leakage of enzymes into extracellular space [20,21]. Pre- and post-
treatment with TPE largely modulated the severity of CCl4-induced
liver damage. Enzyme levels’ return to near-normal levels in treated rats
shows that TPE can stabilize liver cell membranes and prevent the
leakage of enzymes. Preventing the production of free radicals and
neutralizing them as well as the protection potential of this plant
against hepatotoxins can be other probable reasons for the healing ef-
fect of TPE [22]. Another indicator of damage to liver cells is lipid
peroxidation [23]). In fact, lipid peroxidation shows the imbalance
between the amount of free radicals and antioxidants in the body. That
is, if the amount of antioxidants in the body is less than the amount of
oxidants, these extra oxidants can bind with body’s critical compounds
including the double bonds of membrane and cause damage [24].
The results of MDA measurement in this study revealed that pre-
treatment with TPE in all doses except for the dose of 40 mg/kg and
post-treatment just with the dose of 120 mg/kg decreased lipid perox-
idation. Some previous studies have indicated that compounds such as
isoquercetin, kaempferol, sabinene, tannins, and ﬂavonoids can prevent
lipid peroxidation and damage to cells [25,26]. Regarding that TPE also
contains these compounds as well as other antioxidants such as ﬂava-
nols, apigenin, and luteolin, the decrease of lipid peroxidation in the
groups treated with TPE might be due to the presence of scavenger
compounds in it [27]. These ﬁndings were consistent with the ﬁndings
Fig. 5. The eﬀect of TPE on the level of plasma total antioxidant capacity (TAC) in CCl4-
damaged rats. The bar signs on top of the columns indicate mean ± standard deviation
(n = 6). * shows the signiﬁcance of diﬀerences relative to the normal control group
(P < 0.001). ** shows the signiﬁcance of diﬀerences relative to the exposure group
(P < 0.05). † shows signiﬁcance of diﬀerences relative to the damage control group
(P < 0.001).
Fig. 6. Macroscopic images of liver tissue in the groups under study. A: normal group, B: exposure group, C: pretreatment with 40 mg/kg TPE, D: pretreatment with 80 mg/kg TPE, E:
pretreatment with 120 mg/kg TPE, F: pretreatment with 100 mg/kg silymarin, G: post-treatment with 80 mg/kg TPE, H: post-treatment with 120 mg/kg TPE, and I: post-treatment with
100 mg/kg silymarin.
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of Hussain et. al.’s study in which they indicated that Alcea Rosea ex-
tract has antioxidant properties against free radicals due to having
isoquercetin and kaempferol [25].
Liver plays a fundamental role in the metabolism of lipids, carbo-
hydrates, and proteins. Injection of CCl4 caused a signiﬁcant increase in
the triglyceride, total cholesterol, and LDL levels and decrease in HDL
level. The decrease in protein synthesis and disruption in the metabo-
lism of phospholipids might be involved in abnormal lipoprotein levels.
Administration of TPE in both pre- and post-treatment groups modu-
lated lipid proﬁles. Increase in the cholesterol levels might be due to the
increased esteriﬁcation of fatty acids, inhibition of fatty acid β-oxida-
tion, and decreased excretion of cellular lipids [28]. CCl4 stimulates the
transfer of acetate into liver cells (probably by increasing access to
acetate) and leads to an increase in cholesterol synthesis. It also in-
creases the synthesis of fatty acids and triglyceride from acetate and
enhances lipid esteriﬁcation [7]. The accumulation of triglyceride in
liver might occur due to the inhibition of lysosomal lipase activity and
VLDL secretion [29]. Some research studies have also reported that
during toxicity by CCl4, fats stored in peripheral adipose tissue are
transported to liver and kidney and accumulated there [30,31,7].
Moreover, the ﬁndings of Kamalakkannan et al.’s study indicated that
CCl4 also inhibits the synthesis of apo-lipoprotein which in consequence
reduces the synthesis of lipoproteins [32]. Pretreatment with 80 and
120 mg/kg and post-treatment with 120 mg/kg TPE decreased choles-
terol, triglyceride, and LDL levels and increased HDL level. From among
the antioxidant compounds, phenolic compounds are the strongest in
inhibiting lipid peroxidation [32]. Compounds containing hydroxyl
group, especially those having it at ortho position, can easily give
electron to free radicals. Regarding that TPE is rich with hydroxyl-
containing sesquiterpene compounds [33], it can probably inhibit the
damaging eﬀects of ROS and prevent LDL and cell membrane oxidation.
This action, on the one hand, causes the decrease of acetate transport to
liver cells which results in a decrease in the synthesis of cholesterol, free
fatty acids, and triglyceride. On the other hand, by increasing HDL
production and decreasing LDL production, it facilitates the breakdown
of acetate by liver. These ﬁndings of our study were consistent with the
ﬁndings of other studies [32,29,34].
Liver is the main site of protein synthesis, especially albumin. In this
study, albumin was used to assess liver synthetic function [35]. The
increase in albumin level after the injection of TPE indicates that this
extract can prevent the decrease of albumin probably through stabi-
lizing endoplasmic reticulum and resynthesizing protein or through
neutralizing ROS by scavenger compounds.
Antioxidant enzymes are sensitive to severe damage to cells [36]. It
can be said that the decrease in SOD, GPx, and CAT levels indicates
severe damage to liver by CCl4. Damage to liver following the injection
of CCl4 is the result of lipid peroxidation induced by the free radicals
derived from CCl4. Therefore, antioxidant activity and the inhibition of
free radical production are important in preventing CCl4-induced he-
patopathies. The body has eﬀective defense mechanisms to prevent and
neutralize free radicals. This action is ﬁnely accomplished through
regulating endogenous antioxidants such as glutathione peroxidase,
superoxide dismutase, and catalase. These enzymes form a shared
support system against ROS. In CCl4-induced liver damages, the balance
between ROS production and antioxidant defense system of these en-
zymes is disturbed as a result of oxidative stress which disrupts cellular
functions through some events and causes liver damage and necrosis. In
normal conditions, ROS is detoxiﬁed via antioxidant system which
contains both enzymatic and non-enzymatic antioxidants. SOD is a
special antioxidant for the conversion of anyone superoxide to
Fig. 7. H& E stained microscopic images of liver tissue in the groups under study. A: normal group, B: exposure group, C: pretreatment with 40 mg/kg TPE, D: pretreatment with 80 mg/
kg TPE, E: pretreatment with 120 mg/kg TPE, F: pretreatment with 100 mg/kg silymarin, G: post-treatment with 80 mg/kg TPE, H: post-treatment with 120 mg/kg TPE, and I: post-
treatment with 100 mg/kg silymarin.
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hydrogen peroxide which is detoxiﬁed via catalase and glutathione
peroxidase (GSH-px). Therefore, GSH-px uses GSH as the substrate and
excretes free radicals with the cooperation of SOD [37]. Return of the
subjects to normal after being damaged by CCl4 in the groups ad-
ministered with TPE might be due to the ability of this extract to sti-
mulate these antioxidant enzymes to counteract the ROS produced by
CCl4. Non-enzymatic antioxidant systems like GSH determine tissue
sensitivity to oxidative damages. Depletion of liver GSH causes the in-
crease of liver sensitivity to chemical substances like CCl4 and para-
cetamol [38].
Some previous studies have shown that TPE has antidiabetic and
antihyperglycemic eﬀects [39]. In assaying the eﬀect of TPE on blood
glucose, it was observed that CCl4 injection signiﬁcantly increases
blood glucose level in damaged rats. In addition, administration of TPE
in pretreatment groups prevented hyperglycemic eﬀects of CCl4. Re-
garding that liver is the main site of carbohydrate metabolism and its
metabolic pathways including glycolysis, gluconeogenesis, and glyco-
genolysis occur in this part of the body, the reason for the increase in
blood glucose levels in damaged rats might be due to severe damage to
the liver or to the pancreas as the result of interference in the metabolic
pathways of carbohydrates. Some previous ﬁndings have indicated that
the ﬂavonoid substances in the plants have antioxidant and antidiabetic
eﬀects [40]. Considering the fact that TPE is rich with ﬂavonoids, it
seems that the observed eﬀects are related to the return of antioxidant
enzymes to normal levels or the prevention of severe damage to liver or
pancreas [41]. TPE might exert its eﬀects by preventing the destruction
of liver parenchyma via neutralizing ROS.
The hepatoprotective eﬀect of TPE on CCl4-induced liver damage
was further conﬁrmed via histopathological examinations. The liver
samples administered with only CCl4 indicated damages such as va-
cuolization of cells, more percentages of necrosis, and degeneration of
biliary [21]. However, in the groups administered with TPE, less de-
generation was detected and tissue healing was observed after necrosis
and degeneration of biliary in the liver. It seems that the extract of this
plant can prevent liver damage or lead to the reconstruction of da-
maged liver parenchyma.
5. Conclusion
The ﬁndings of this study showed that TPE has antioxidant eﬀects
and can protect liver against damages induced by free radicals which
are produced as the result of CCl4 metabolism. The results also de-
monstrated that the extract of this plant can decrease the abnormally
increased levels of cholesterol and triglyceride which indicates its an-
tihyperlipidemic properties.
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